American Journal of Psychiatry
- Volume 166
- Number 7
- July 2009
In This Issue
Editorial
Commentary
Introspections
Clinical Case Conference
Publication date: 01 July 2009
Pages762–767This case study presents an overview of the conceptualization and treatment of two veterans of the Iraq War who presented for combat-related treatment at a Veterans Administration Medical Center. In addition to posttraumatic stress disorder (PTSD) ...
https://doi.org/10.1176/appi.ajp.2009.08091315Reviews and Overviews
Publication date: 01 July 2009
Pages768–776The authors examine the relationship of the two signature injuries experienced by military personnel serving in Afghanistan and Iraq: posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mild TBI). Studies show that a substantial minority ...
https://doi.org/10.1176/appi.ajp.2009.08101604Article
Publication date: 01 July 2009
Pages777–785Objective: There is increasing interest in the relations between adverse early experiences and subsequent psychiatric disorders. Institutional rearing is considered an adverse caregiving environment, but few studies have systematically examined ...
https://doi.org/10.1176/appi.ajp.2009.08091438Publication date: 01 July 2009
Pages786–794Objective: This study examined effects of bereavement 21 months after a parent’s death, particularly death by suicide. Method: The participants were 176 offspring, ages 7–25, of parents who died by suicide, accident, or ...
https://doi.org/10.1176/appi.ajp.2009.08081244Publication date: 01 July 2009
Pages795–804Objective: The authors sought to assess the longitudinal course of youths with bipolar spectrum disorders over a 4-year period. Method: At total of 413 youths (ages 7–17 years) with bipolar I disorder (N=244), bipolar II ...
https://doi.org/10.1176/appi.ajp.2009.08101569Publication date: 01 July 2009
Pages805–811Objective: Impaired verbal memory in schizophrenia is a key rate-limiting factor for functional outcome, does not respond to currently available medications, and shows only modest improvement after conventional behavioral remediation. The ...
https://doi.org/10.1176/appi.ajp.2009.08050757Publication date: 01 July 2009
Pages812–820Objective: Preclinical and clinical data implicate the group II metabotropic glutamate receptors mGluR2 and mGluR3 in the pathophysiology of schizophrenia. Moreover, a recent phase II clinical trial demonstrated the antipsychotic efficacy of a ...
https://doi.org/10.1176/appi.ajp.2009.08091445Publication date: 01 July 2009
Pages821–827Objective: Recent advances in the assessment of disability in schizophrenia have separated the measurement of functional capacity from real-world functional outcomes. The authors examined the similarity of performance-based assessments of ...
https://doi.org/10.1176/appi.ajp.2009.09010106